164 related articles for article (PubMed ID: 28109009)
1. Using Flow Characteristics in Three-Dimensional Power Doppler Ultrasound Imaging to Predict Complete Responses in Patients Undergoing Neoadjuvant Chemotherapy.
Shia WC; Huang YL; Wu HK; Chen DR
J Ultrasound Med; 2017 May; 36(5):887-900. PubMed ID: 28109009
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of evaluating tumor vascularization using 3D power Doppler ultrasound with high-definition flow technology in the prediction of the response to neoadjuvant chemotherapy for T2 breast cancer: a preliminary report.
Shia WC; Chen DR; Huang YL; Wu HK; Kuo SJ
Phys Med Biol; 2015 Oct; 60(19):7763-78. PubMed ID: 26393306
[TBL] [Abstract][Full Text] [Related]
3. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
Testa AC; Ferrandina G; Moro F; Pasciuto T; Moruzzi MC; De Blasis I; Mascilini F; Foti E; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta MA; Valentini AL; Rufini V; Scambia G
Ultrasound Obstet Gynecol; 2018 May; 51(5):684-695. PubMed ID: 28620930
[TBL] [Abstract][Full Text] [Related]
4. Early Evaluation of Relative Changes in Tumor Stiffness by Shear Wave Elastography Predicts the Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.
Jing H; Cheng W; Li ZY; Ying L; Wang QC; Wu T; Tian JW
J Ultrasound Med; 2016 Aug; 35(8):1619-27. PubMed ID: 27302898
[TBL] [Abstract][Full Text] [Related]
5. Potential application value of Doppler ultrasonography in neoadjuvant chemotherapy for breast cancer.
Santos DW; Fernandes PC; Guedes CA; Debs Diniz AL
Minerva Ginecol; 2016 Aug; 68(4):405-11. PubMed ID: 27302212
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-based prediction of pathologic response to neoadjuvant chemotherapy in breast cancer patients.
Baumgartner A; Tausch C; Hosch S; Papassotiropoulos B; Varga Z; Rageth C; Baege A
Breast; 2018 Jun; 39():19-23. PubMed ID: 29518677
[TBL] [Abstract][Full Text] [Related]
7. Can the power Doppler mode predict tumor response in neoadjuvant chemotherapy breast cancer patients according to the intrinsic tumor subtypes?
Guedes C; Santos D; Fernandes PC; Lajolo P; Diniz A
Minerva Ginecol; 2016 Oct; 68(5):621-62. PubMed ID: 27430202
[No Abstract] [Full Text] [Related]
8. Value of three-dimensional power Doppler to predict clinical and histological response to neoadjuvant chemotherapy in locally advanced cervical carcinoma.
Qin J; Cheng X; Chen X; Zhang X; Lu W; Xie X
Ultrasound Obstet Gynecol; 2012 Feb; 39(2):226-34. PubMed ID: 21845741
[TBL] [Abstract][Full Text] [Related]
9. Does color Doppler ultrasound vascularity predict the response to neoadjuvant chemotherapy in breast cancer?
Boonjunwetwat D; Prueksadee J; Sampatanukul P; Chatamra K
J Med Assoc Thai; 2005 Oct; 88(10):1367-72. PubMed ID: 16519381
[TBL] [Abstract][Full Text] [Related]
10. Vascularity change and tumor response to neoadjuvant chemotherapy for advanced breast cancer.
Kuo WH; Chen CN; Hsieh FJ; Shyu MK; Chang LY; Lee PH; Liu LY; Cheng CH; Wang J; Chang KJ
Ultrasound Med Biol; 2008 Jun; 34(6):857-66. PubMed ID: 18374468
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy.
Saracco A; Szabó BK; Tánczos E; Bergh J; Hatschek T
Acta Radiol; 2017 Apr; 58(4):394-402. PubMed ID: 27461224
[TBL] [Abstract][Full Text] [Related]
12. The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.
Park JS; Moon WK; Lyou CY; Cho N; Kang KW; Chung JK
Acta Radiol; 2011 Feb; 52(1):21-8. PubMed ID: 21498321
[TBL] [Abstract][Full Text] [Related]
13. Spatial registration of temporally separated whole breast 3D ultrasound images.
Narayanasamy G; LeCarpentier GL; Roubidoux M; Fowlkes JB; Schott AF; Carson PL
Med Phys; 2009 Sep; 36(9):4288-300. PubMed ID: 19810503
[TBL] [Abstract][Full Text] [Related]
14. Prospective trial of breast MRI versus 2D and 3D ultrasound for evaluation of response to neoadjuvant chemotherapy.
Lee MC; Gonzalez SJ; Lin H; Zhao X; Kiluk JV; Laronga C; Mooney B
Ann Surg Oncol; 2015 Sep; 22(9):2888-94. PubMed ID: 25589151
[TBL] [Abstract][Full Text] [Related]
15. Vascular morphologic information of three-dimensional power Doppler ultrasound is valuable in the classification of breast lesions.
Yen PL; Wu HK; Tseng HS; Kuo SJ; Huang YL; Chen HT; Chen DR
Clin Imaging; 2012; 36(4):267-71. PubMed ID: 22726963
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of ultrasound doppler parameters in neoadjuvant chemotherapy response of breast cancer: Prospective comparison with magnetic resonance and mammography.
Conz L; Jales RM; Dória MT; Melloni I; Cres Lyrio CA; Menossi C; Derchain S; Sarian LO
PLoS One; 2024; 19(6):e0302527. PubMed ID: 38833499
[TBL] [Abstract][Full Text] [Related]
17. Computer-aided diagnosis for breast tumors by using vascularization of 3-D power Doppler ultrasound.
Huang YL; Kuo SJ; Hsu CC; Tseng HS; Hsiao YH; Chen DR
Ultrasound Med Biol; 2009 Oct; 35(10):1607-14. PubMed ID: 19647918
[TBL] [Abstract][Full Text] [Related]
18. Solid breast masses: neural network analysis of vascular features at three-dimensional power Doppler US for benign or malignant classification.
Chang RF; Huang SF; Moon WK; Lee YH; Chen DR
Radiology; 2007 Apr; 243(1):56-62. PubMed ID: 17312276
[TBL] [Abstract][Full Text] [Related]
19. Role of color Doppler indices in predicting disease-free survival of breast cancer patients during neoadjuvant chemotherapy.
Singh G; Kumar P; Parshad R; Seith A; Thulkar S; Hosten N
Eur J Radiol; 2010 Aug; 75(2):e158-62. PubMed ID: 20071116
[TBL] [Abstract][Full Text] [Related]
20. Utility of MRI and PET/CT after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity.
Kim T; Kang DK; An YS; Yim H; Jung YS; Kim KS; Kang SY; Kim TH
Acta Radiol; 2014 May; 55(4):399-408. PubMed ID: 23963151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
